全文获取类型
收费全文 | 7986篇 |
免费 | 465篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 254篇 |
妇产科学 | 125篇 |
基础医学 | 1115篇 |
口腔科学 | 360篇 |
临床医学 | 590篇 |
内科学 | 1983篇 |
皮肤病学 | 237篇 |
神经病学 | 756篇 |
特种医学 | 105篇 |
外科学 | 800篇 |
综合类 | 31篇 |
一般理论 | 2篇 |
预防医学 | 702篇 |
眼科学 | 185篇 |
药学 | 533篇 |
中国医学 | 31篇 |
肿瘤学 | 617篇 |
出版年
2024年 | 12篇 |
2023年 | 95篇 |
2022年 | 190篇 |
2021年 | 331篇 |
2020年 | 196篇 |
2019年 | 287篇 |
2018年 | 283篇 |
2017年 | 197篇 |
2016年 | 202篇 |
2015年 | 255篇 |
2014年 | 343篇 |
2013年 | 460篇 |
2012年 | 686篇 |
2011年 | 698篇 |
2010年 | 346篇 |
2009年 | 298篇 |
2008年 | 486篇 |
2007年 | 496篇 |
2006年 | 453篇 |
2005年 | 417篇 |
2004年 | 401篇 |
2003年 | 329篇 |
2002年 | 291篇 |
2001年 | 78篇 |
2000年 | 77篇 |
1999年 | 74篇 |
1998年 | 49篇 |
1997年 | 34篇 |
1996年 | 36篇 |
1995年 | 19篇 |
1994年 | 23篇 |
1993年 | 15篇 |
1992年 | 51篇 |
1991年 | 25篇 |
1990年 | 30篇 |
1989年 | 23篇 |
1988年 | 15篇 |
1987年 | 15篇 |
1986年 | 15篇 |
1985年 | 17篇 |
1984年 | 15篇 |
1982年 | 7篇 |
1981年 | 8篇 |
1980年 | 11篇 |
1979年 | 10篇 |
1977年 | 7篇 |
1976年 | 7篇 |
1975年 | 8篇 |
1972年 | 10篇 |
1970年 | 7篇 |
排序方式: 共有8484条查询结果,搜索用时 15 毫秒
51.
S Monfardini S M L Aversa V Zoli L Salvagno A Bianco R Bordonaro G Benevolo M Crugnola G Crivellari P Vivaldi U Basso V Torri 《Annals of oncology》2005,16(8):1352-1358
BACKGROUND: Frail patients with non-Hodgkin's lymphoma (NHL) are generally excluded from clinical trials and not even treated. The aim of this study was to evaluate the efficacy and tolerability of vinorelbine and prednisone in frail elderly patients with NHL. PATIENTS AND METHODS: Thirty consecutive frail elderly patients were entered in a phase II study with vinorelbine 25 mg/m2 i.v. on days 1 and 8 and oral prednisone 30 mg total dose on days 1-8 for six cycles. Criteria of frailty were age > or =80 years, or age > or =70 years and three or more comorbidities of grade 3 or at least one comorbidity of grade 4 according to the Cumulative Illness Rating Scale (CIRS), or not self-sufficient or the presence of one or more geriatric syndromes. RESULTS: Of 30 evaluable patients, three (10.0%) achieved a complete response (CR), nine (30.0%) showed a partial response (PR), while 10 presented with stable disease and eight with progressive disease. The median duration of CR was 29 months (range 5-36 months), and the median duration of PR was 1 month (range 1-22 months). Three patients had grade 3 neutropenia and one had grade 4. One grade 4 neurotoxicity was observed. Three patients died because of heart failure within 28 days of therapy, and one patient died after 4 days because of rapid progression. The median overall survival was only 10 months. CONCLUSION: Vinorelbine and prednisone is a relatively non-toxic combination with modest activity in frail patients with NHL. If initial aggressive chemotherapy has been excluded, this combination could be tried to obtain a temporary palliation. 相似文献
52.
M Lanciotti C Dufour L Corral P Di Michele S Pigullo G De Rossi G Basso A Leszl M Luciani L Lo Nigro C Micalizzi M G Valsecchi A Biondi R Haupt 《Leukemia》2005,19(2):214-216
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a detoxification enzyme that protects cells against oxidative stress and toxic quinones. A polymorphism (C609T) in the gene produces in the heterozygous individuals (C/T) a reduction and in those homozygous for the variant allele (T/T) the abolishment of NQO1 protein activity. To assess whether NQO1 inactivating polymorphism (CT/TT) was a possible risk factor for infant acute lymphoblastic leukemia (iALL), we investigated the distribution of NQO1 genotype in 50 iALL patients, 32 with MLL gene rearrangements (MLL+) and 18 without (MLL-). As controls, 106 cases of pediatric ALL (pALL), and 147 healthy subjects were also studied. Compared to normal controls, the frequency of the low/null activity NQO1 genotypes was significantly higher in the iALL MLL- (72 vs 38%, P=0.006; odds ratio (OR) 4.22, 95% confidence interval (CI) 1.43-12.49), while no differences were observed in iALL MLL+ (44 vs 38%, P=0.553; OR 1.26, 95% CI 0.58-2.74). Similar results were observed when pALL were used as control. Our results indicate that only the iALL patients without MLL rearrangements had a significantly higher frequency of NQO1 genotypes associated with low/null activity enzyme, suggesting a possible role for NQO1 gene as an MLL-independent risk factor, in the leukemogenic process of this subtype of iALL. 相似文献
53.
Andrea Pession Maria Grazia Valsecchi Giuseppe Masera Willem A Kamps Edina Magyarosy Carmelo Rizzari Elisabeth R van Wering Luca Lo Nigro Anna van der Does Franco Locatelli Giuseppe Basso Maurizio Aricò 《Journal of clinical oncology》2005,23(28):7161-7167
PURPOSE: Between September 1991 and May 1997, within the International Berlin-Frankfurt-Muenster Study Group (I-BFM-SG), a randomized study was performed aimed at assessing the efficacy of prolonged use of high-dose l-asparaginase (HD-l-ASP) during continuation therapy in children with standard risk (SR) acute lymphoblastic leukemia (ALL), treated with a reduced BFM-type chemotherapy. PATIENTS AND METHODS: The Italian, Dutch, and Hungarian groups participated in this study denominated IDH-ALL-91, and 494 children were enrolled. Treatment consisted of a BFM-type modified backbone with omission of the IB part in induction and elimination of two doses of anthracyclines during reinduction in both arms at the beginning of continuation therapy. Patients were randomly assigned to receive (YES-ASP) or not (NO-ASP) 20 weekly HD-l-ASP (25,000 IU/m2). RESULTS: The event-free-survival and overall survival probabilities at 10 years for the entire group were 82.5% (1.8) and 90.3% (1.3), respectively. Of the 490 patients eligible for random assignment, 355 (72.4%) were randomly assigned (178 YES-ASP and 177 NO-ASP). After a median follow-up of 9 years, the probability of disease-free survival at 10 years was 87.5% (SE, 2.5) for YES-ASP arm versus 78.7% (SE, 3.3) for NO-ASP arm (P = .03). In multivariate analysis, NO-ASP arm (P = .03), male sex (P = .004), and age older than 10 years (P = .0003) had a significantly adverse impact on outcome. CONCLUSION: In this subset of patients, selected with criteria not including monitoring of minimal residual disease, application of extended HD-l-ASP may improve prognosis, compensating reduced leukemia control that results from adoption of a reduced-intensity BFM-backbone for treatment of children with SR ALL. 相似文献
54.
Fran?oise V Botelho Luciana R Enéas Giovana C Cesar Carolina S Bizzotto Erico Tavares Fabrícia A Oliveira M Beatriz A Gloria Marialice P C Silvestre Rosa M E Arantes Jacqueline I Alvarez-Leite 《Food and chemical toxicology》2004,42(8):1259-1267
Eggplant (Solanum melongena) has been used as hypocholesterolemic agent in many countries. However, few controlled studies were addressed to this subject and atherogenesis. We have evaluated the effect of eggplant on cholesterol metabolism and atherogenesis in LDLR(-/-) mice. Animals were fed on chow (n=17) or atherogenic (n=21) diet during 12 weeks receiving water (control) or eggplant extract. Liver, serum and fecal lipids, together with serum lipoproteins were measured. Oxidative stress was evaluated through conjugate diene formation and ox-LDL antibodies by enzyme immunoassay. Atherosclerotic lesions were measured in different sites of aorta. Total cholesterol and atherogenic lipoproteins did not decrease after eggplant intake. Animals receiving eggplant and chow diet showed increased anti-ox-LDL antibodies and a decreased lag phase of conjugated diene formation, indicating a higher oxidative stress than controls. No differences were seen in lesion area of aortic valve. Eggplant extract had high histamine and other amine levels that could enhance LDL oxidation and its endocytosis. Eggplant did not decrease plasma cholesterol nor prevent the development of atherosclerosis in LDLR(-/-) mice. Surprisingly, eggplant increased oxidative stress, representing a risk factor for atherosclerosis. These results did not support the use of eggplant extract as hypocholesterolemic agent. 相似文献
55.
Simon P. Jochems Karin de Ruiter Carla Solrzano Astrid Voskamp Elena Mitsi Elissavet Nikolaou Beatriz F. Carniel Sherin Pojar Esther L. German Jesús Rein Alessandra Soares-Schanoski Helen Hill Rachel Robinson Angela D. Hyder-Wright Caroline M. Weight Pascal F. Durrenberger Robert S. Heyderman Stephen B. Gordon Hermelijn H. Smits Britta C. Urban Jamie Rylance Andrea M. Collins Mark D. Wilkie Lepa Lazarova Samuel C. Leong Maria Yazdanbakhsh Daniela M. Ferreira 《The Journal of clinical investigation》2022,132(11)
56.
Lina Widerspick Cecilia Alejandra Vzquez Linda Niemetz Michelle Heung Catherine Olal Andrs Bencsik Christoph Henkel Anneke Pfister Jesús Emanuel Brunetti Indre Kucinskaite-Kodze Philip Lawrence Csar Muoz Fontela Sandra Diederich Beatriz Escudero-Prez 《Viruses》2022,14(5)
Nipah virus (NiV) is an emerging zoonotic paramyxovirus that causes severe disease in humans and livestock. Due to its high pathogenicity in humans and the lack of available vaccines and therapeutics, NiV needs to be handled in biosafety level 4 (BSL-4) laboratories. Safe inactivation of samples containing NiV is thus necessary to allow further processing in lower containment areas. To date, there is only limited information available on NiV inactivation methods validated by BSL-4 facilities that can be used as a reference. Here, we compare some of the most common inactivation methods in order to evaluate their efficacy at inactivating NiV in infected cells, supernatants and organs. Thus, several physical and chemical inactivation methods, and combinations thereof, were assessed. Viral replication was monitored for 3 weeks and NiV presence was assessed by RT-qPCR, plaque assay and indirect immunofluorescence. A total of nineteen methods were shown to reduce NiV infectious particles in cells, supernatants and organs to undetectable levels. Therefore, we provide a list of methods for the safe and efficient inactivation of NiV. 相似文献
57.
Andreas Hoefer Silvia Herrera-Len Lucas Domínguez Maria Ordobs Gavín Beatriz Romero Ximena Belen Araujo Piedra Cristina Sobrino Calzada María Jos Uría Gonzlez Laura Herrera-Len Case Study Investigation Group 《Emerging infectious diseases》2022,28(6):1257
Toxigenic Corynebacterium ulcerans is as an emerging zoonotic agent of diphtheria. We describe the zoonotic transmission of diphtheria caused by toxigenic C. ulcerans from domestic animals in Spain, confirmed by core-genome multilocus sequence typing. Alongside an increasing number of recent publications, our findings highlight the public health threat posed by diphtheria reemergence. 相似文献
58.
The popular medicine Passiflora edulis has been used as a sedative, tranquilizer, against cutaneous inflammatory diseases and intermittent fever. Most of the pharmacological investigations of Passiflora edulis have been addressed to its Central Nervous System activities, such as anxiolytic, anticonvulsant and sedative actions. Otherwise, there are few reports about the anti-inflammatory activity of the Passiflora species. The aim of this study was to investigate the mechanism of the anti-inflammatory effect of aqueous lyophilized extract obtained from leaves of Passiflora edulis var. flavicarpa Degener (Passifloraceae) in the mouse model of pleurisy induced by carrageenan (Cg), bradykinin, histamine or substance P, observing the effects upon leucocytes migration, myeloperoxidase (MPO), nitric oxide (NO) concentrations and tumor necrosis factor-alpha (TNFalpha) and interleukin-1 beta (IL-1beta) levels. RESULTS: Passiflora edulis (250mg/kg) administered by intraperitoneal route (i.p.) inhibited the leukocyte, neutrophils, myeloperoxidase, nitric oxide, TNFalpha and IL-1beta levels (P<0.01) in the pleurisy induced by carrageenan. Passiflora edulis (250-500mg/kg, i.p.) also inhibited total and differential leukocytes in the pleurisy induced by bradykinin, histamine or substance P (P<0.05). CONCLUSION: Several mechanisms, including the inhibition of pro-inflammatory cytokines (TNFalpha, IL-1beta), enzyme (myeloperoxidase) and mediators (bradykinin, histamine, substance P, nitric oxide) release and/or action, appear to account for Passiflora edulis's actions. 相似文献
59.
Francisco Salazar Luis San FrutosVirginia Engels Beatriz BuenoTirso Pérez-Medina Inmaculada OrensanzJosé Bajo 《Progresos de Obstetricia y Ginecología》2008
Objective
To measure endometrial thickness and characterize ultrasonographic endometrial images induced by tamoxifen, as well as to determine changes in ultrasonographic patterns throughout treatment.Patients and methods
We analyzed 278 patients with breast cancer between 1995 and 2000 under adjuvant therapy with tamoxifen for 5 years. Annual ultrasonographic examination was performed. Endometrial thickness and the morphological endometrial patterns in stored ultrasonographic images were retrospectively analyzed.Results
Endometrial thickness significantly increased during treatment from a mean of 7.84 mm in the first year to 16.67 mm in the fifth year. Five endometrial patterns were found on ultrasonography in patients receiving tamoxifen: linear, heterogeneous-hyperechoic, homogeneoushyperechoic, endometrial polyp, and suspicious for malignancy. The homogeneous-hyperechoic pattern predominated in the first year and the heterogeneous-hyperechoic pattern in the fifth year.Conclusions
Tamoxifen increases endometrial thickness in the course of treatment and induces five ultrasonographic patterns which change year-by-year. 相似文献60.
de Macena Sobreira NL Alves MT Alvarez Perez AB Brunoni D Cernach MC 《Clinical dysmorphology》2008,17(2):145-148
We describe a stillborn female with acrofacial dysostosis and frontonasal dysplasia. She had protrusion of the forehead, with marked hypertelorism and absence of the nose but with the rhinencephalon present. Autopsy showed wide cranial sutures, severe hydrocephalus with separation of the right and left hemispheres of the brain, preservation of the olfactory bulb and first and second cranial nerves. The child also had small kidneys bilaterally, rectal atresia and an absent anus with rectovaginal fistula. These clinical findings suggest a new form of acrofacial dysostosis. 相似文献